Cargando…

Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is replacing hepatitis B as the leading cause of chronic liver disease in China. The purpose of this study is to select good tools to identify NAFLD from the body composition, anthropometry and related routine clinical parameters. A total of 5076 steelworker...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shengkui, Wang, Lihua, Yu, Miao, Guan, Weijun, Yuan, Juxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684573/
https://www.ncbi.nlm.nih.gov/pubmed/36418352
http://dx.doi.org/10.1038/s41598-022-23729-1
_version_ 1784835317836021760
author Zhang, Shengkui
Wang, Lihua
Yu, Miao
Guan, Weijun
Yuan, Juxiang
author_facet Zhang, Shengkui
Wang, Lihua
Yu, Miao
Guan, Weijun
Yuan, Juxiang
author_sort Zhang, Shengkui
collection PubMed
description Non-alcoholic fatty liver disease (NAFLD) is replacing hepatitis B as the leading cause of chronic liver disease in China. The purpose of this study is to select good tools to identify NAFLD from the body composition, anthropometry and related routine clinical parameters. A total of 5076 steelworkers, aged 22–60 years, was included in this study. Body fat mass was measured via bioelectrical impedance analysis (BIA) and fat mass index (FMI) was derived. Ultrasonography method was used to detect hepatic steatosis. Random forest classifier and best subset regression were used to select useful parameters or models that can accurately identify NAFLD. Receiver operating characteristic (ROC) curves were used to describe and compare the performance of different diagnostic indicators and algorithms including fatty liver index (FLI) and hepatic steatosis index (HSI) in NAFLD screening. ROC analysis indicated that FMI can be used with high accuracy to identify heavy steatosis as determined by ultrasonography in male workers [area under the curve (AUC) 0.95, 95% CI 0.93–0.98, sensitivity 89.0%, specificity 91.4%]. The ability of single FMI to identify NAFLD is no less than that of combination panels, even better than the combination panel of HSI. The best subset regression model that including FMI, waist circumference, and serum levels of triglyceride and alanine aminotransferase has moderate accuracy in diagnosing overall NAFLD (AUC 0.83). FMI and the NAFLD best subset (BIC) score seem to be good tools to identify NAFLD in Chinese steelworkers.
format Online
Article
Text
id pubmed-9684573
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96845732022-11-25 Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease Zhang, Shengkui Wang, Lihua Yu, Miao Guan, Weijun Yuan, Juxiang Sci Rep Article Non-alcoholic fatty liver disease (NAFLD) is replacing hepatitis B as the leading cause of chronic liver disease in China. The purpose of this study is to select good tools to identify NAFLD from the body composition, anthropometry and related routine clinical parameters. A total of 5076 steelworkers, aged 22–60 years, was included in this study. Body fat mass was measured via bioelectrical impedance analysis (BIA) and fat mass index (FMI) was derived. Ultrasonography method was used to detect hepatic steatosis. Random forest classifier and best subset regression were used to select useful parameters or models that can accurately identify NAFLD. Receiver operating characteristic (ROC) curves were used to describe and compare the performance of different diagnostic indicators and algorithms including fatty liver index (FLI) and hepatic steatosis index (HSI) in NAFLD screening. ROC analysis indicated that FMI can be used with high accuracy to identify heavy steatosis as determined by ultrasonography in male workers [area under the curve (AUC) 0.95, 95% CI 0.93–0.98, sensitivity 89.0%, specificity 91.4%]. The ability of single FMI to identify NAFLD is no less than that of combination panels, even better than the combination panel of HSI. The best subset regression model that including FMI, waist circumference, and serum levels of triglyceride and alanine aminotransferase has moderate accuracy in diagnosing overall NAFLD (AUC 0.83). FMI and the NAFLD best subset (BIC) score seem to be good tools to identify NAFLD in Chinese steelworkers. Nature Publishing Group UK 2022-11-23 /pmc/articles/PMC9684573/ /pubmed/36418352 http://dx.doi.org/10.1038/s41598-022-23729-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhang, Shengkui
Wang, Lihua
Yu, Miao
Guan, Weijun
Yuan, Juxiang
Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
title Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
title_full Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
title_fullStr Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
title_full_unstemmed Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
title_short Fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
title_sort fat mass index as a screening tool for the assessment of non-alcoholic fatty liver disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684573/
https://www.ncbi.nlm.nih.gov/pubmed/36418352
http://dx.doi.org/10.1038/s41598-022-23729-1
work_keys_str_mv AT zhangshengkui fatmassindexasascreeningtoolfortheassessmentofnonalcoholicfattyliverdisease
AT wanglihua fatmassindexasascreeningtoolfortheassessmentofnonalcoholicfattyliverdisease
AT yumiao fatmassindexasascreeningtoolfortheassessmentofnonalcoholicfattyliverdisease
AT guanweijun fatmassindexasascreeningtoolfortheassessmentofnonalcoholicfattyliverdisease
AT yuanjuxiang fatmassindexasascreeningtoolfortheassessmentofnonalcoholicfattyliverdisease